← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksVREXRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

VREX logoVarex Imaging Corporation (VREX) Revenue History

Annual and quarterly revenue from 2014 to 2025

TTM Revenue
$857.5M
vs. $811.0M LY
YoY Growth
+1.5%
Slow
Latest Quarter
$216.0M
Q2 2026
QoQ Growth
+3.1%
Slow

Compound Annual Growth Rate (CAGR)

3-Year-0.6%Declining
5-Year+2.7%Slow
10-Year+2.9%Slow
Highest Annual Revenue$893.4M (2023)
Highest Quarter$232.2M (Q3 2023)
Revenue per Share$20.46
Revenue per Employee$373K

Loading revenue history...

VREX Revenue Growth

1-Year Growth
+1.5%
Slow
3-Year CAGR
-0.6%
Declining
5-Year CAGR
+2.7%
Slow
10-Year CAGR
+2.9%
Slow
TTM vs Prior Year+$46.5M (+5.7%)
Revenue per Share$20.46
Revenue per Employee$372,826.087
Peak Annual Revenue$893.4M (2023)

Revenue Breakdown (FY 2024)

VREX's revenue distribution by segment and geography for fiscal year 2024

By Product/Segment

Medical Segment71.7%
Industrial Segment28.3%

By Geography

EMEA26.2%
Americas24.9%
Asia Pacific24.7%
UNITED STATES24.1%

Download Historical Data

12 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

VREX Revenue Analysis (2014–2025)

As of May 8, 2026, Varex Imaging Corporation (VREX) generated trailing twelve-month (TTM) revenue of $857.5 million, reflecting modest growth of +1.5% year-over-year. The most recent quarter (Q2 2026) recorded $216.0 million in revenue, up 3.1% sequentially.

Looking at the longer-term picture, VREX's 5-year compound annual growth rate (CAGR) stands at +2.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $893.4 million in 2023.

Revenue diversification analysis shows VREX's business is primarily driven by Medical Segment (72%), and Industrial Segment (28%). With over half of revenue concentrated in Medical Segment, the company maintains significant focus in this area while developing other growth vectors.

When compared to Healthcare sector peers including XRAY (-1.0% YoY), NNOX (+15.2% YoY), and ATEC (-7.4% YoY), VREX has underperformed the peer group in terms of revenue growth. Compare VREX vs XRAY →

VREX Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
VREX logoVREXCurrent$858M+1.5%+2.7%-3.3%
XRAY logoXRAY$3.7B-1.0%+2.0%6.8%
NNOX logoNNOX$11M+15.2%--502.9%
ATEC logoATEC$764M-7.4%+39.5%-10.7%
HOLX logoHOLX$4.1B+2.2%+1.7%17.4%
ISRG logoISRG$10.1B+21.4%+18.2%29.3%
Best in groupLowest in group

VREX Historical Revenue Data (2014–2025)

Showing 10 of 12 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$844.6M+4.1%$290.5M34.4%$-27,800,000-3.3%
2024$811.0M-9.2%$256.9M31.7%$32.1M4.0%
2023$893.4M+4.0%$290.3M32.5%$77.1M8.6%
2022$859.4M+5.0%$283.5M33.0%$88.2M10.3%
2021$818.1M+10.8%$271.5M33.2%$74.1M9.1%
2020$738.3M-5.4%$190.2M25.8%$-33,700,000-4.6%
2019$780.6M+0.9%$256.7M32.9%$8.2M1.1%
2018$773.4M+10.8%$253.9M32.8%$44.5M5.8%
2017$698.1M+12.6%$253.5M36.3%$83.7M12.0%
2016$620.1M-1.9%$248.4M40.1%$109.1M17.6%

See VREX's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is VREX Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare VREX vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

VREX — Frequently Asked Questions

Quick answers to the most common questions about buying VREX stock.

Is VREX's revenue growth accelerating or slowing?

VREX revenue growth slowed to +1.5%, below the 5-year CAGR of +2.7%. TTM revenue is $858M. The deceleration marks a shift from historical growth rates.

What is VREX's long-term revenue growth rate?

Varex Imaging Corporation's 5-year revenue CAGR of +2.7% reflects the variable expansion pattern. Current YoY growth of +1.5% is near this long-term average.

How is VREX's revenue distributed by segment?

VREX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

VREX Revenue Over Time (2014–2025)